Showing results (61-70 of 92) with videos related to
Sort By:
Pageof 10
Cell Death & Disease|January 16, 2023
Single-cell RNA-seq integrated with multi-omics reveals SERPINE2 as a target for metastasis in advanced renal cell carcinomaWen-Jin Chen, Ke-Qin Dong, Xiu-Wu Pan, et al.BMJ Oncology|January 31, 2025
Association between neutrophil-to-eosinophil ratio and efficacy outcomes with avelumab plus axitinib or sunitinib in patients with advanced renal cell carcinoma: post hoc analyses from the JAVELIN Renal 101 trialMatthew Tucker, Yu-Wei Chen, Martin H Voss, et al.Cancer|July 20, 2012
Pericyte coverage of differentiated vessels inside tumor vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinomaYun Cao, Zhi-Ling Zhang, Ming Zhou, et al.Cancer|June 14, 2012
AMG 386 in combination with sorafenib in patients with metastatic clear cell carcinoma of the kidney: a randomized, double-blind, placebo-controlled, phase 2 studyBrian Rini, Cezary Szczylik, Nizar M Tannir, et al.Urologic Oncology|January 7, 2023
Comparative real-world survival outcomes of metastatic papillary and clear cell renal cell carcinoma treated with immunotherapy, targeted therapy, and combination therapyCarlos Riveros, Sanjana Ranganathan, Jiaqiong Xu, et al.European Urology|January 4, 2022
Molecular Genetic Determinants of Shorter Time on Active Surveillance in a Prospective Phase 2 Clinical Trial in Metastatic Renal Cell CarcinomaOscar Reig Torras, Akhilesh Mishra, Alana Christie, et al.Cancer Immunology Research|October 1, 2016
Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate CancerXiao X Wei, Stephen Chan, Serena Kwek, et al.Journal of Neurosurgery|January 20, 2019
Overall survival and response to radiation and targeted therapies among patients with renal cell carcinoma brain metastasesAditya Juloori, Jacob A Miller, Shireen Parsai, et al.Clinical Genitourinary Cancer|December 28, 2020
Summary from the Kidney Cancer Association's Inaugural Think Thank: Coalition for a CureBrian Rini, E Jason Abel, Laurence Albiges, et al.JCO Global Oncology|February 29, 2020
Outcomes in Black and White Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors: Insights From Two Large CohortsDominick Bossé, Wanling Xie, Xun Lin, et al.Pageof 10